as of now. Both set to strongly outperform in coming quarters. AMHI is profitable and just started selling FDA approved infrared camera for breast cancer screening - something I know that top doctors are recommending to patients.
APTD has some warts (dilution, lawsuits, A/R's, RFID?) - but is outperforming and undervalued.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.